Correlation Between Dogwood Therapeutics, and EnGene Holdings

Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dogwood Therapeutics, and enGene Holdings Common, you can compare the effects of market volatilities on Dogwood Therapeutics, and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and EnGene Holdings.

Diversification Opportunities for Dogwood Therapeutics, and EnGene Holdings

-0.04

Correlation Coefficient

Dogwood Therapeutics,  EnGene Holdings

Good diversification

The 3 months correlation between Dogwood and EnGene is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and EnGene Holdings go up and down completely randomly.

Pair Corralation between Dogwood Therapeutics, and EnGene Holdings

Given the investment horizon of 90 days Dogwood Therapeutics, is expected to generate 4.88 times more return on investment than EnGene Holdings. However, Dogwood Therapeutics, is 4.88 times more volatile than enGene Holdings Common. It trades about 0.12 of its potential returns per unit of risk. enGene Holdings Common is currently generating about -0.02 per unit of risk. If you would invest  285.00  in Dogwood Therapeutics, on December 29, 2024 and sell it today you would earn a total of  313.00  from holding Dogwood Therapeutics, or generate 109.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Dogwood Therapeutics,  vs.  enGene Holdings Common

Dogwood Therapeutics,

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dogwood Therapeutics, are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Dogwood Therapeutics, showed solid returns over the last few months and may actually be approaching a breakup point.

enGene Holdings Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days enGene Holdings Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Etf's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the ETF investors.

Pair Trading with Dogwood Therapeutics, and EnGene Holdings

The main advantage of trading using opposite Dogwood Therapeutics, and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.

The idea behind Dogwood Therapeutics, and enGene Holdings Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.